IE
PHAT icon

Israel Englander’s Phathom Pharmaceuticals PHAT Stock Holding History

Israel Englander’s Portfolio PHAT Stock Details PHAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.6M Sell
3,375,834
-647,075
-16% -$7.38M 0.01% 1110
2026
Q1 		$44.7M Buy
4,022,909
+1,940,729
+93% +$24.5M 0.02% 904
2025
Q4 		$34.5M Sell
2,082,180
-2,999,271
-59% -$42.8M 0.01% 1070
2025
Q3 		$59.8M Buy
5,081,451
+2,830,954
+126% +$29.2M 0.03% 743
2025
Q2 		$21.6M Buy
2,250,497
+1,727,134
+330% +$9.56M 0.01% 1504
2025
Q1 		$3.28M Buy
523,363
+463,372
+772% +$2.81M ﹤0.01% 3296
2024
Q4 		$487K Buy
59,991
+27,063
+82% +$335K ﹤0.01% 4772
2024
Q3 		$595K Buy
+32,928
New +$460K ﹤0.01% 4692
2024
Q2 		– Sell
-225,024
Closed -$2.39M – 6374
2024
Q1 		$2.39M Buy
225,024
+54,980
+32% +$467K ﹤0.01% 3572
2023
Q4 		$1.55M Buy
170,044
+30,696
+22% +$264K ﹤0.01% 3809
2023
Q3 		$1.45M Buy
139,348
+111,407
+399% +$1.53M ﹤0.01% 3881
2023
Q2 		$400K Sell
27,941
-29,922
-52% -$345K ﹤0.01% 4697
2023
Q1 		$413K Buy
+57,863
New +$508K ﹤0.01% 4718
2022
Q4 		– Sell
-50,396
Closed -$558K – 6928
2022
Q3 		$558K Buy
+50,396
New +$480K ﹤0.01% 4872
2021
Q2 		– Sell
-12,090
Closed -$454K – 6963
2021
Q1 		$454K Sell
12,090
-61,287
-84% -$2.56M ﹤0.01% 4898
2020
Q4 		$2.44M Buy
+73,377
New +$2.97M ﹤0.01% 3086

Other funds holding PHAT

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Israel Englander's PHAT Position: Q2 2026 in Review

Israel Englander reduced its Phathom Pharmaceuticals (PHAT) stake by 16% in Q2 2026, selling an estimated $7.38M and leaving 3,375,834 shares worth $36.6M. The position accounts for 0.01% of the portfolio, ranked #1110.

Israel Englander first reported a position in PHAT in Q4 2020 and has held it in 16 quarters since. The position peaked at $59.8M in Q3 2025. 161 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

  • Israel Englander held 3,375,834 shares of Phathom Pharmaceuticals worth $36.6M as of Q2 2026.
  • Israel Englander sold 647,075 Phathom Pharmaceuticals shares in Q2 2026, an estimated $7.38M.
  • Phathom Pharmaceuticals made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1110 holding.
  • Israel Englander first reported a position in Phathom Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
  • Israel Englander's Phathom Pharmaceuticals position peaked at $59.8M in Q3 2025.
  • 161 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.